Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics - Summary - MDSpire

Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics

  • By

  • Mindong Mi

  • Tianhuan Xiong

  • Jiyong Gong

  • Weijie Sun

  • Tunguang Xu

  • Qifeng Jiang

  • Danqing Zhang

  • Junge Zhang

  • Jiancheng Huang

  • Wei Liang

  • June 22, 2026

  • 0 min

Share

Objective:

To evaluate and identify urinary biomarkers for the early diagnosis and staging of diabetic kidney disease (DKD).

Approach:
    Key Findings:
    • UTRF and UIgG demonstrated excellent diagnostic value with AUCs of 0.926 and 0.916, respectively.
    • A combined model of 20 urinary amino acids showed outstanding diagnostic value (AUC = 0.928).
    • SERPINA1 was identified as a key protein with exceptional diagnostic capability (AUC = 0.964).
    • Among the amino acids, PRO showed the best diagnostic performance (AUC = 0.746).
    Interpretation:

    Traditional proteins, especially UTRF and UIgG, hold diagnostic value.

    Limitations:
    • The study's findings may not be generalizable beyond the specific population studied.
    • Further validation in larger, diverse cohorts is necessary.
    Conclusion:

    This study identifies urinary SERPINA1 as a promising biomarker for DKD.

Original Source(s)

Related Content